First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the treatment of de novo native coronary artery lesions: MeRes-1 trial.
Seth A, Onuma Y, Costa R, Chandra P, Bahl VK, Manjunath CN, Mahajan AU, Kumar V, Goel PK, Wander GS, Kalarickal MS, Kaul U, Kumar VKA, Rath PC, Trehan V, Sengottuvelu G, Mishra S, Abizaid A, Serruys PW.
Seth A, et al. Among authors: onuma y.
EuroIntervention. 2017 Jul 20;13(4):415-423. doi: 10.4244/EIJ-D-17-00306.
EuroIntervention. 2017.
PMID: 28504218
Free article.
Clinical Trial.